Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104592118A reveals a novel solvent-free synthesis for saturated imidazolinium salts, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN115611756B reveals visible light catalysis for glycine derivatives, offering cost reduction in agrochemical manufacturing and high-purity supply chain solutions.
Patent CN110092746B reveals a green, high-yield route for 2-amino-5-halopyridines using 4-cyano-1-butyne, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN115611756B reveals a visible-light photocatalytic method for α-substituted glycine derivatives, offering mild conditions and scalable agrochemical intermediate manufacturing.
Patent CN109776381B details a green aqueous synthesis for spiro indolones using quaternary ammonium iodide, offering significant cost reduction and supply chain reliability.
Patent CN108997193B reveals a cobalt-catalyzed C-H activation method for difluoroalkyl heterocycles, offering cost-effective synthesis for pharma and agrochemical applications.
Patent CN112341417A details a novel light/copper co-catalyzed route for polysubstituted furans, offering mild conditions and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN114832862A reveals a cost-effective nickel-catalyzed route for fluorinated isoquinoline-1,3-diones, offering significant supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN112441875B reveals a green copper photocatalytic route for 9-trifluoromethyl-9,10-dihydrophenanthrene, offering mild conditions and high atom economy for pharmaceutical intermediates.
Patent CN101973954A reveals a green, aqueous synthesis route for 3,4-dihydro-1,3-oxazin-2-ones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102070586A introduces a mild hydrazone-based route for 4-heteroatom cyclohexenyl halides. Avoids cryogenic temps, ensures >97% purity, scalable for API manufacturing.
Novel Raney-Ni catalyzed hydrogenation reduces steps for 2 4 6 trifluorobenzylamine ensuring high purity and cost reduction in pharma intermediate manufacturing.
Patent CN103510104A reveals a green electrochemical route for 2-mercaptobenzothiazole metal compounds, offering high purity and waste reduction for agrochemical and rubber industries.
Patent CN114369044A introduces a continuous method using modified skeletal nickel, offering high purity reactive dye intermediates with reduced production costs.
Patent CN101805307B reveals a magnetic nano-catalytic route for tetrazole synthesis, offering high purity, easy separation, and significant cost reduction for pharmaceutical supply chains.
Patent CN118702710A enables metal-free visible light catalysis for organoboron compounds, ensuring high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110498781B reveals a green alcohol-based synthesis of D,L-pantolactone eliminating solvent extraction, reducing wastewater, and ensuring high yields for Vitamin B5 production.
Patent CN108659043B details a cost-effective CAN-catalyzed route for E-alkenyl diphenylphosphines, offering superior atom economy and simplified purification for pharmaceutical intermediates.
Patent CN109776422A reveals advanced copper-catalyzed asymmetric hydroboration for chiral alkyl borides, offering significant supply chain and cost advantages.
Novel pyridine-amide-oxazoline ligands enable high-yield asymmetric hydroboration. Efficient synthesis reduces costs for pharmaceutical intermediate manufacturing supply chains.